Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity

Severe obesity (SO) can accelerate atherosclerosis and the onset of acute cardiovascular events. The diagnosis of atherosclerosis in the context of a high body mass index (BMI) can be challenging, making the identification of biomarkers clinically relevant. We aimed to assess the usefulness of irisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmona-Maurici, Júlia, Rosa, Araceli, Azcona-Granada, Natalia, Peña, Elionora, Ricart-Jané, David, Viñas, Anna, López-Tejero, Maria Dolores, Domingo, Joan Carles, Miñarro, Antonio, Baena-Fustegueras, Juan Antonio, Peinado-Onsurbe, Julia, Pardina, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179106/
https://www.ncbi.nlm.nih.gov/pubmed/37175880
http://dx.doi.org/10.3390/ijms24098171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179106/
https://www.ncbi.nlm.nih.gov/pubmed/37175880
http://dx.doi.org/10.3390/ijms24098171

Ejemplares similares